SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from GENOMIC HEALTH INC (CIK 0001131324) — Sep 27, 2005

GENOMIC HEALTH INC (CIK 0001131324)
Date: Sept. 27, 2005 · CIK: 0001131324 · Accession: 0000891618-05-000753

AI Filing Summary & Sentiment

File numbers found in text: 333-126626

Date
September 27, 2005
Author
Not clearly detected
Form
CORRESP
Company
GENOMIC HEALTH INC (CIK 0001131324)

Letter

PILLSBURY WINTHROP SHAW PITTMAN LLP

P.O. BOX 7880

SAN FRANCISCO, CA 94120

Tel: (415) 983-1000

Fax: (415) 983-1200

September 27, 2005

VIA FACSIMILE AND ELECTRONIC TRANSMISSION

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C. 20549

Mail Stop 6010

Attn: Mr. Albert C. Lee, Staff Attorney

Re:

Genomic Health, Inc.

Registration Statement on Form S-1 (File No. 333-126626)

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, and by letter filed on Edgar on September 26, 2005 (the “Acceleration Request”), Genomic Health, Inc. (the “Registrant”) requested that the Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1, relating to the registration of 5,769,230 shares of the Registrant’s Common Stock, to become effective at 4:00 p.m. (Eastern Daylight Time) on September 28, 2005, or as soon thereafter as possible.

On behalf of the Registrant and in connection with the Acceleration Request, the Registrant acknowledges each of the following:

(a) should the Commission or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

(b) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

(c) the Registrant may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If you have any questions, please do not hesitate to call me at (415) 983-6117.

Yours very truly,

/s/ Justin D. Hovey

Justin D. Hovey

cc:

Randal W. Scott, Ph.D.

G. Bradley Cole

S.D. Wong

G.A. Lombardi

Show Raw Text
CORRESP
1
filename1.htm

corresp

PILLSBURY WINTHROP SHAW PITTMAN LLP

P.O. BOX 7880

SAN FRANCISCO, CA 94120

Tel: (415) 983-1000

Fax: (415) 983-1200

September 27, 2005

VIA FACSIMILE AND ELECTRONIC TRANSMISSION

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C. 20549

Mail Stop 6010

Attn: Mr. Albert C. Lee, Staff Attorney

    Re:

    Genomic Health, Inc.

Registration Statement on Form S-1 (File No. 333-126626)

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, and by letter filed on Edgar on
September 26, 2005 (the “Acceleration Request”), Genomic Health, Inc. (the “Registrant”) requested
that the Commission take appropriate action to cause the above-referenced Registration Statement on
Form S-1, relating to the registration of 5,769,230 shares of the Registrant’s Common Stock, to
become effective at 4:00 p.m. (Eastern Daylight Time) on September 28, 2005, or as soon thereafter
as possible.

On behalf of the Registrant and in connection with the Acceleration Request, the Registrant
acknowledges each of the following:

     (a) should the Commission or the staff, acting pursuant to delegated authority, declare the
Registration Statement effective, it does not foreclose the Commission from taking any action with
respect to the Registration Statement;

     (b) the action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the Registration Statement effective, does not relieve the Registrant from its full
responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

     (c) the Registrant may not assert this action as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the United States.

If you have any questions, please do not hesitate to call me at (415) 983-6117.

Yours very truly,

/s/ Justin D. Hovey

Justin D. Hovey

    cc:

    Randal W. Scott, Ph.D.

G. Bradley Cole

S.D. Wong

G.A. Lombardi